| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22
|
Sharkey, Robert M.
|
|
1997
|
44 |
3 |
p. 179-188
|
artikel
|
| 2 |
Intratumoral infusion of the monoclonal antibody, mAb 425, against the epidermal-growth-factor receptor in patients with advanced malignant glioma
|
Wersäll, P.
|
|
1997
|
44 |
3 |
p. 157-164
|
artikel
|
| 3 |
Oligoclonal in vitro response of CD4 T cells to vesicles of mistletoe extracts in mistletoe-treated cancer patients
|
Fischer, Sonja
|
|
1997
|
44 |
3 |
p. 150-156
|
artikel
|
| 4 |
Phase IB trial of picibanil (OK-432) as an immunomodulator in patients with resected high-risk melanoma
|
Kirkwood, John M.
|
|
1997
|
44 |
3 |
p. 137-149
|
artikel
|
| 5 |
Postural effects on peritoneal transport and systemic uptake of radiolabeled monoclonal antibodies
|
Barrett, Jeffrey S.
|
|
1997
|
44 |
3 |
p. 173-178
|
artikel
|
| 6 |
Role of macrophage-colony-stimulating factor in regulating the accumulation and phenotype of tumor-associated macrophages
|
Dougherty, S. T.
|
|
1997
|
44 |
3 |
p. 165-172
|
artikel
|
| 7 |
Toxicological and immunological evaluation of the MHC-non-restricted cytotoxic T cell line TALL-104
|
Cesano, Alessandra
|
|
1997
|
44 |
3 |
p. 125-136
|
artikel
|
Tijdschrift beschrijving